Press Releases

Mesquite, Nevada – September 6, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sell up to $10 million of shares to White Lion Capital, LLC (White Lion), a California-based institutional investor. Under the terms of the purchase agreement, UHP will have the […]

Henderson, Nevada – July 15, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application.   On July 13 the company and its regulatory consultant met with the full FDA team assigned to review its Class III PMA application. The focus of the meeting was […]

Henderson, Nevada – June 16, 2022 – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021.   UHP has agreed with the Securities and Exchange Commission (the Commission) to […]

Henderson, Nevada – May 18, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process.   Regulatory Review As previously disclosed, on April 20, 2022, UHP delivered to the U.S. Food & Drug Administration (FDA) a supplemented and e-formatted Premarket Approval (PMA) response for its HemoStyp™ hemostatic […]

Henderson, Nevada – April 27, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process and other matters.   Regulatory Review As previously disclosed in the company’s Form 10-K, the U.S. Food & Drug Administration (FDA) requested in late January 2022 that i) the responses submitted by UHP […]

Henderson, Nevada – April 1, 2022 – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its regulatory process, business condition, and other matters.   Regulatory Approvals Following the submission in October, 2021 of a response to the FDA’s questions and comments on its Premarket Approval (PMA) application, UHP and the FDA held […]